A Study of TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)

Clinical trial NCT05150340 · COMPLETED

Trial details

NCT number: NCT05150340
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases (PID)

Start date: 2022-01-24
Primary completion: 2023-08-28
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.